Skip to main content

Table 2 Pharmacokinetic parameters of carboplatin in the first and second cycle of gemcitabine plus carboplatin chemotherapy

From: Investigation of tolerability and quality of life for carboplatin-based chemotherapy in an elderly urothelial carcinoma patient undergoing hemodialysis: a case report

Treatment phase

First cycle

Second cycle

Measured AUC (mg/mL min)

Ke (h−1)

t1/2 (h)

CL (mL/min)

Measured AUC (mg/mL min)

Ke (h−1)

t1/2 (h)

CL (mL/min)

Pre-dialysis

0.88

0.150

4.6

0.47

0.211

3.3

During dialysis

0.74

0.281

2.5

0.66

0.300

2.3

Post-dialysis

4.34

0.017

40.8

3.84

0.015

46.2

Total

5.96

26.8

4.97

27.2

  1. Carboplatin dose in the first and second cycle were 160 mg and 135 mg, respectively. The time interval between the carboplatin infusion and hemodialysis initiation in the first and second cycle were two hours and one hour, respectively
  2. AUC area under the concentration–time curve of carboplatin, Ke elimination rate constant, t1/2 elimination half-life, CL clearance